SCREENswitch: Switchable Opacity Patient Isolation Systems

SCREENswitch:可切换不透明患者隔离系统

基本信息

  • 批准号:
    79146
  • 负责人:
  • 金额:
    $ 7.63万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Small Business Research Initiative
  • 财政年份:
    2020
  • 资助国家:
    英国
  • 起止时间:
    2020 至 无数据
  • 项目状态:
    已结题

项目摘要

Many people have been put into isolation in hospitals due to COVID-19 and this will continue into the future if the pandemic persists. Using partition screens is one of the most hygienic ways to segregate patients but they are limited by the fact that they are either opaque or transparent. There is need for both options, as patients require privacy but also must not be left to feel completely secluded; there are well documented negative mental health impacts on patients who have undergone extended periods of isolation. There is therefore a need for patients who are isolated in hospitals to have both the option of privacy, and to be able to see the rest of their ward. SCREENswitch is a feasibility study to understand whether Smart Glass, which switches from being opaque to clear at the click of a button, can be used in creating retractable hospital screening partitions. These would transform the delivery of in-ward patient isolation, giving the patient the control over their environment, minimising the stress on their mental health. Currently, there is no solution that allows for a clear infection control screen to become opaque at the touch of a button. Instead, an external product must be used alongside the clear screen to allow for privacy. These products, such as curtains, are usually unhygienic and inconvenient to use. Most worryingly, 90% of curtains used in NHS hospitals are made of disposable polypropylene, disposed of by incineration or landfill every few months, which is damaging the environment. Working with UCLH, SCREENswitch would help lead to a more sustainable public sector, by creating an easy-to-clean and therefore reusable product that can ultimately replace single-use curtains in hospitals with an innovative, sustainable alternative. It would help the NHS recover from the COVID-19 pandemic and implement better isolation systems to prevent further spread of infectious diseases in hospitals and reduce the mental health effects of isolation in the future. KwickScreen has over a decade of experience in designing, manufacturing and selling retractable privacy and infection control screens to hospitals. The company's screens can be found in every NHS trust and their equivalents in the UK. SCREENswitch will work with a specialist producer of Smart Glass. The two companies, who are both local to each other, will work together to carry out this feasibility study, and later development, of creating a switchable-opacity isolation system.
许多人因COVID-19而被隔离在医院,如果疫情持续,这种情况将持续到未来。使用隔离屏是隔离患者的最卫生的方法之一,但它们受到不透明或透明的事实的限制。这两种选择都是必要的,因为病人需要隐私,但也不能让他们感到完全与世隔绝;有充分证据表明,长期隔离对病人的心理健康有负面影响。因此,在医院隔离的病人需要既有隐私的选择,又能看到病房的其他地方。SCREENswitch是一项可行性研究,旨在了解智能玻璃是否可以用于创建可伸缩的医院筛选分区。这将改变病房内病人隔离的方式,使病人能够控制他们的环境,最大限度地减少对他们心理健康的压力。目前,还没有允许在触摸按钮时使清晰的感染控制屏幕变得不透明的解决方案。相反,外部产品必须与清晰的屏幕一起使用,以保护隐私。这些产品,如窗帘,通常不卫生,使用不方便。最令人担忧的是,NHS医院使用的窗帘90%是由一次性聚丙烯制成的,每隔几个月就通过焚烧或填埋处理,这对环境造成了破坏。与UCLH合作,SCREENswitch将通过创造一种易于清洁且可重复使用的产品,最终可以用创新的可持续替代品取代医院中的一次性窗帘,从而帮助建立一个更具可持续性的公共部门。这将有助于NHS从COVID-19大流行中恢复过来,并实施更好的隔离系统,以防止传染病在医院进一步传播,并减少未来隔离对心理健康的影响。KwickScreen在设计、制造和向医院销售可伸缩隐私和感染控制屏幕方面拥有十多年的经验。该公司的屏幕可以在英国的每一个NHS信托基金和同等机构中找到。SCREENswitch将与智能玻璃的专业生产商合作。这两家公司都是本地公司,将共同开展这项可行性研究,并在以后开发一个可切换的不透明隔离系统。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

其他文献

吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
生命分子工学・海洋生命工学研究室
生物分子工程/海洋生物技术实验室
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:

的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('', 18)}}的其他基金

An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
  • 批准号:
    2901954
  • 财政年份:
    2028
  • 资助金额:
    $ 7.63万
  • 项目类别:
    Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
  • 批准号:
    2896097
  • 财政年份:
    2027
  • 资助金额:
    $ 7.63万
  • 项目类别:
    Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
  • 批准号:
    2780268
  • 财政年份:
    2027
  • 资助金额:
    $ 7.63万
  • 项目类别:
    Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
  • 批准号:
    2908918
  • 财政年份:
    2027
  • 资助金额:
    $ 7.63万
  • 项目类别:
    Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
  • 批准号:
    2908693
  • 财政年份:
    2027
  • 资助金额:
    $ 7.63万
  • 项目类别:
    Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
  • 批准号:
    2908917
  • 财政年份:
    2027
  • 资助金额:
    $ 7.63万
  • 项目类别:
    Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
  • 批准号:
    2879438
  • 财政年份:
    2027
  • 资助金额:
    $ 7.63万
  • 项目类别:
    Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
  • 批准号:
    2890513
  • 财政年份:
    2027
  • 资助金额:
    $ 7.63万
  • 项目类别:
    Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
  • 批准号:
    2879865
  • 财政年份:
    2027
  • 资助金额:
    $ 7.63万
  • 项目类别:
    Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
  • 批准号:
    2876993
  • 财政年份:
    2027
  • 资助金额:
    $ 7.63万
  • 项目类别:
    Studentship

相似海外基金

REDOX-Switchable Pyrazinacenes as a New Class of Near-Infrared Active Chromophores for Bio and Cellular Imaging Applications
氧化还原可切换吡嗪并苯作为一类新型近红外活性发色团,用于生物和细胞成像应用
  • 批准号:
    24K08401
  • 财政年份:
    2024
  • 资助金额:
    $ 7.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A New Strategy for Switchable Magnetic Interactions Trigered by Structure Change due to External Stimuli
外部刺激引起的结构变化触发可切换磁相互作用的新策略
  • 批准号:
    23KJ0970
  • 财政年份:
    2023
  • 资助金额:
    $ 7.63万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Switchable Persistent Spin Helix Devices
可切换的持续自旋螺旋装置
  • 批准号:
    2314614
  • 财政年份:
    2023
  • 资助金额:
    $ 7.63万
  • 项目类别:
    Standard Grant
NSF/MCB-BSF: De novo design of minimalistic light-switchable protein binding domains
NSF/MCB-BSF:简约光可切换蛋白结合域的从头设计
  • 批准号:
    2306190
  • 财政年份:
    2023
  • 资助金额:
    $ 7.63万
  • 项目类别:
    Standard Grant
Electrically Switchable Ferromagnetic Josephson Junctions
电可切换铁磁约瑟夫森结
  • 批准号:
    2828359
  • 财政年份:
    2023
  • 资助金额:
    $ 7.63万
  • 项目类别:
    Studentship
Finding NEMO's Switchable MRI Signal Using Microfluidic Tumor Models
使用微流控肿瘤模型寻找 NEMO 的可切换 MRI 信号
  • 批准号:
    10652001
  • 财政年份:
    2023
  • 资助金额:
    $ 7.63万
  • 项目类别:
CAS-SC: Thermally Switchable Organic Solvents for Targeted Harvesting of Lithium Ions from Alkali Metal Cations Mixtures in Hypersaline Brines
CAS-SC:用于从超咸盐水中的碱金属阳离子混合物中定向收获锂离子的热可切换有机溶剂
  • 批准号:
    2327627
  • 财政年份:
    2023
  • 资助金额:
    $ 7.63万
  • 项目类别:
    Standard Grant
Developing Switchable Ligands to Control Gold Nanocluster Interfaces
开发可切换配体来控制金纳米团簇界面
  • 批准号:
    DE230100138
  • 财政年份:
    2023
  • 资助金额:
    $ 7.63万
  • 项目类别:
    Discovery Early Career Researcher Award
Smart Photodynamic Therapy for Acne by Reversibly Switchable Intersystem Crossing in Pure Organic Materials
通过纯有机材料中的可逆可切换系间交叉来治疗痤疮的智能光动力疗法
  • 批准号:
    10483461
  • 财政年份:
    2022
  • 资助金额:
    $ 7.63万
  • 项目类别:
Next generation PHOTACS: A light switchable system for enhanced spatial and temporal precision in targeted protein degradation
下一代 PHOTACS:光可切换系统,可增强目标蛋白质降解的空间和时间精度
  • 批准号:
    2753267
  • 财政年份:
    2022
  • 资助金额:
    $ 7.63万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了